With an office in Peru since 2007, PPD understands how to work within the country’s regulatory environment to offer clients quality research, fast trial enrollment and expedited drug development. We tap into the country’s unique disease demographics to help clients develop multiple therapies.
The country’s population of more than 28 million enables access to many treatment-naïve patients. Also, a clearly defined, efficient regulatory environment creates a streamlined drug approval process, while experienced sites and staff create a productive research environment.
Learn about the benefits and challenges of conducting clinical trials in Latin America. Download our white paper.
